RHR for My+ Versus My− ALL Patients
. | BL . | TL . | Cross-Strata . | |||
---|---|---|---|---|---|---|
. | My+ BL . | My− BL . | My+ TL . | My− TL . | My+ ALL . | My− ALL . |
Observed events | 35 | 209 | 11 | 41 | 46 | 250 |
Expected events | 40.81 | 203.19 | 9.68 | 42.32 | 50.49 | 245.51 |
O/E | 0.86 | 1.03 | 1.14 | 0.97 | 0.91 | 1.02 |
RHR | 0.83 | |||||
1.18 | ||||||
0.89 | ||||||
P value4-150 | .32 | |||||
.64 | ||||||
.49 | ||||||
. | BL . | TL . | Cross-Strata . | |||
---|---|---|---|---|---|---|
. | My+ BL . | My− BL . | My+ TL . | My− TL . | My+ ALL . | My− ALL . |
Observed events | 35 | 209 | 11 | 41 | 46 | 250 |
Expected events | 40.81 | 203.19 | 9.68 | 42.32 | 50.49 | 245.51 |
O/E | 0.86 | 1.03 | 1.14 | 0.97 | 0.91 | 1.02 |
RHR | 0.83 | |||||
1.18 | ||||||
0.89 | ||||||
P value4-150 | .32 | |||||
.64 | ||||||
.49 | ||||||
P values were calculated from a global chi-square statistic.